Atlas Copco AB ATLAS COPCO SERIES.../ SE0017486897 /
2024-05-24 6:36:56 PM | Chg. -1.94 | Volume | Bid2024-05-24 | Ask2024-05-24 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
175.53SEK | -1.10% | 131,571 Turnover: 11.69 mill. |
-Bid Size: - | -Ask Size: - | 956.27 bill.SEK | 1.60% | 30.48 |
GlobeNewswire
05-23
Victory Square Company Announces Access to Tirzepatide and GLP-1 Injections to its Weight Loss Portf...
GlobeNewswire
05-23
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atla...
GlobeNewswire
05-22
Deepfence CNAPP Adds Runtime Protection and API Security for Generative AI Applications
GlobeNewswire
05-20
Avalyn Presents Clinical Data on AP01 for Pulmonary Fibrosis, Including Long-Term Efficacy and Imagi...
GlobeNewswire
05-14
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atla...
GlobeNewswire
05-13
Avalyn Announces Multiple Presentations on its Lead Program, AP01, for Pulmonary Fibrosis and its Ap...
GlobeNewswire
05-06
Fortinet Threat Research Finds Cybercriminals Are Exploiting New Industry Vulnerabilities 43% Faster...
GlobeNewswire
04-25
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
04-25
Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes ...
GlobeNewswire
04-18
OpenDrives New Software-Defined Platform Atlas Wins 2024 NAB Show Product of the Year Award
GlobeNewswire
04-11
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC
GlobeNewswire
04-10
Oxurion Receives EUR 450,000 in the framework of the Atlas Funding Program : Eleventh tranche fully ...